FDA Plans to Ban Fluoride Supplements for Children

The U.S. Food and Drug Administration (FDA) is moving to ban fluoride-based oral supplements for children, citing growing concerns about potential risks to brain development. The proposed regulation, announced this week, would apply to tablets, lozenges, and drops commonly prescribed to prevent tooth decay in areas without fluoridated water.

Recent scientific studies have linked high fluoride intake to neurodevelopmental issues, including lower IQ scores, thyroid dysfunction, and disruption of gut microbiota in children. Health advocacy groups and researchers have increasingly called for federal action, warning that fluoride exposure may have more serious effects than previously understood.

Under the new proposal, manufacturers would be required to halt distribution of these supplements for pediatric use. The FDA noted that topical fluoride in toothpaste and dental treatments would remain available, as current evidence shows fewer systemic risks when applied externally.

The final decision on the rule is expected by October 31, following a period of public comment.

Pediatric and dental organizations remain divided. While some experts welcome the move as a necessary step toward child safety, others argue it may increase the risk of cavities in underserved areas. The American Dental Association has not yet released an official statement.